NFE2L2 and cancer: Furthermore, our analysis revealed a scarcity of cancer somatic mutations in the interfaces of complexes involving two oncogene products, NRF2 (the NRF2‐MAF1 interface) and TRRAP (interfaces involving the FAT domain of TRRAP), suggesting critical functions of these protein complexes in cancer cells.